Distribution of paroxetine in three postmortem cases

Journal of Analytical Toxicology

Volumn 22, Issue 6, 1998, Pages 541-544

  Vermeulen, Tanya ^a  

^a Orange County Sheriff Department   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BUTALBITAL; CAFFEINE; CHARCOAL; CYTOCHROME P450; DESIPRAMINE; FLUOXETINE; IMIPRAMINE; NORFLUOXETINE; PAROXETINE; SALICYLIC ACID; SERTRALINE; TRIFLUOPERAZINE;

ADULT; ARTICLE; AUTOPSY; CASE REPORT; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; FEMALE; GAS CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; MALE; MANIC DEPRESSIVE PSYCHOSIS; SUICIDE;

EID: 0031669989     PISSN: 01464760     EISSN: None     Source Type: Journal    
DOI: 10.1093/jat/22.6.541     Document Type: Article

References (17)

1. C.M. Kaye, R.E. Haddock, P.F. Langley, G. Mellows, T.C.G. Tasker, B.D. Zussman, and W.H. Greb. A review of the metabolism and pharmacokinetics of paroxetine in man. Acta. Psychiatr. Scand. Suppl. 80: 60-75 (1989).
2. S.H. Preskorn, and R.D. Magnus. Inhibition of hepatic p-450 isoenzymes by serotonin selective reuptake inhibitors: in vitro and in vivo findings and their implications for patient care. Psychopharmacol. Bull. 30(2): 251-259 (1994).
3. S.H. Preskorn. Pharmacokinetics of antidepressants: why and how they are relevant to treatment. J. Clin. Psychiatry 54(9) suppl.: 14-34 (1993).
4. D.A. Vaughan. Interaction of fluoxetine with tricyclic antidepressants. Am. J. Psychiatry 145: 1478 (1988).
5. K. Brosen, J.G. Hansen, K.K. Nielsen, S.H. Sindrup, and L.F. Gram. Inhibition by paroxetine of desipramine metabolism in extensive but not in poor metabolisers of sparteine. Eur. J. Clin. Pharmacol. 44(4): 349-355 (1993a).
6. P. Robert, J.M. Senard, M. Fabre, C. Cabot, and B. Cathala. Serotonin syndrome from antidepressant overdose. Ann. Fr. Anest. Reanim. 15: 663-665 (1996).
7. J. Beno. Selective serotonin reuptake inhibitors: analysis and interpretation. Presented at Society of Forensic Toxicologists annual meeting, Denver, Colorado, 1996.
8. ®), TIAFT Bulletin, Vol XXVII(1), 1997.
9. R. Baselt and R. Cravey. Paroxetine. In Disposition of Toxic Drugs and Chemicals in Man, 4th ed. Chemical Toxicology Institute Foster City, CA, 1995, pp 586-588.
10. P.P. Singer and G.R. Jones. An uncommon fatality due to meclobemideand paroxetine. J. Anal. Toxicol. 21: 518-520 (1997).
11. S.E. German, T. Rice, and H.F. Simmons. Paroxetine overdose Am. J. Emerg. Med. 11: 682 (1993).
12. ® (paroxetine). In Physicians Desk Reference, 51st ed. Medical Economics Company, Montvale, NJ, 1997, pp 2681-2686.
13. T.P. Rohrig and R.W. Prouty. Fluoxetine overdose: a case report. J. Anal. Toxicol. 13: 305-307 (1989).
14. E. Skjelbo and K. Brosen. Inhibitors of imipramine metabolism by human liver microsomes. Br. J. Clin. Pharmacol. 34: 256-261 (1992).
15. J. Lazarou, B.H. Pomeranz, and P.N. Corey. Incidence of adverse drug reactions in hospitalized patients. J. Am. Med. Assoc. 279(15)-1200-1205 (1998).
16. T.C. Kupiec, L.V. Allen, G.P. Basmadjian, D.V. Canfield, A.K. Chaturvedi, C.L. Blank, and D. Parker. Post mortem redistribution of paroxetine using the rat as a model. Presented at The American Academy of Forensic Sciences annual meeting San Francisco, California, 1998.
17. R.W. Prouty and W.H. Anderson. The forensic science implications of site and temporal influences on postmortem blood-drug concentrations. J. Forensic Sci. 35(2): 243-270 (1990).